EMS-Chemie Holding AG

Explore how Swiss specialty‑chemical Ems‑Chemie turns lower revenue into higher margins, boosts dividends, and targets EV‑EV & circular‑economy growth amid regulatory and geopolitical risks.

Explore Ems‑Chemie’s 2025 results: modest revenue dip but higher earnings and an 80 % dividend boost, driven by cost control and high‑value products.

EMS‑Chemie’s stock dipped to 615 CHF after UBS’s buy upgrade, yet the company’s resilient valuation, high‑performance polymer focus and positive analyst outlook make it a steady pick for investors in the growing materials sector.

EMS-Chemie Holding AG’s stock price has experienced fluctuations due to various market factors, including global economic conditions and investor sentiment.

EMS-Chemie Holding AG’s financial news is impacted by US-EU trade tensions, with the company’s exports vulnerable to potential 30% tariffs on goods from the EU.

EMS-Chemie Holding AG’s stock price has declined 27.56% over the past three years, with a recent rating downgrade from Berenberg to “sell” contributing to the decline.